VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 168 filers reported holding VIKING THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,307,000 | +4.8% | 208,102 | 0.0% | 0.48% | +7.2% |
Q2 2021 | $1,247,000 | -5.2% | 208,102 | 0.0% | 0.44% | -21.3% |
Q1 2021 | $1,316,000 | +7.2% | 208,102 | -4.6% | 0.56% | +1.3% |
Q4 2020 | $1,228,000 | -3.2% | 218,102 | 0.0% | 0.56% | -25.4% |
Q3 2020 | $1,269,000 | -19.3% | 218,102 | 0.0% | 0.74% | -13.3% |
Q2 2020 | $1,573,000 | +54.1% | 218,102 | 0.0% | 0.86% | +33.4% |
Q1 2020 | $1,021,000 | -41.6% | 218,102 | 0.0% | 0.64% | -9.2% |
Q4 2019 | $1,749,000 | +16.5% | 218,102 | 0.0% | 0.71% | +12.4% |
Q3 2019 | $1,501,000 | -17.1% | 218,102 | 0.0% | 0.63% | -17.4% |
Q2 2019 | $1,810,000 | -16.5% | 218,102 | 0.0% | 0.76% | -11.6% |
Q1 2019 | $2,168,000 | +19.1% | 218,102 | -8.4% | 0.86% | +0.9% |
Q4 2018 | $1,821,000 | -55.8% | 238,102 | +0.6% | 0.86% | -36.0% |
Q3 2018 | $4,122,000 | +76.2% | 236,600 | -4.1% | 1.34% | +52.5% |
Q2 2018 | $2,340,000 | +121.2% | 246,600 | +1.9% | 0.88% | +101.1% |
Q1 2018 | $1,058,000 | +12.3% | 242,000 | +4.3% | 0.44% | +16.3% |
Q4 2017 | $942,000 | – | 232,000 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |